- Home
- EVO vs ODD Comparison
EVO vs ODD Comparison
Compare EVO & ODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EVO | ODD |
|---|---|---|
| Founded | 1993 | 2018 |
| Country | Germany | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 568.6M | 634.2M |
| IPO Year | 2007 | 2022 |
Fundamental Metrics
Financial Performance| Metric | EVO | ODD |
|---|---|---|
| Price | $1.66 | $18.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 11 |
| Target Price | $4.17 | ★ $15.31 |
| AVG Volume (30 Days) | 153.5K | ★ 1.7M |
| Earning Date | 11-05-2026 | 11-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $20.51 | $14.12 |
| P/E Ratio | ★ N/A | $16.73 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.50 | $9.25 |
| 52 Week High | $4.27 | $60.49 |
Technical Indicators
Market Signals| Indicator | EVO | ODD |
|---|---|---|
| Relative Strength Index (RSI) | 46.64 | 60.64 |
| Support Level | $1.50 | $11.71 |
| Resistance Level | $1.97 | $19.87 |
| Average True Range (ATR) | 0.05 | 1.03 |
| MACD | 0.02 | -0.02 |
| Stochastic Oscillator | 76.00 | 72.69 |
Price Performance
Historical ComparisonAbout EVO Evotec SE
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
About ODD ODDITY Tech Ltd.
ODDITY Tech Ltd offers a consumer tech platform that is built to transform the beauty and wellness market. The ODDITY platform is designed to support a portfolio of brands and services that innovate and disrupt the expansive beauty and wellness market. It consumes user data to develop physical beauty and wellness products that deliver performance and functionality. Its brands include SpoiledChild and IL Makiage. Geographically, the company generates majority revenue from United states followed by other countries and Israel.